In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Imperial increases holding in Veryan:

This article was originally published in Clinica

Executive Summary

Veryan Medical (Horsham, UK) has received £1.6m ($3.1m) in financial backing from Imperial Innovations, which increased its existing shareholding in the company to 39%. Veryan are aiming to profit from the $5bn stent market with its patented Swirlflow technology used in the treatment of vascular disease. Swirlflow reproduces helical geometry naturally found in the body and introduces a swirling motion to the arteries, in order to reduce restenosis.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts